<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>Perfüzyonistlik Bölümü</title>
<link href="http://hdl.handle.net/11513/90" rel="alternate"/>
<subtitle>Perfüzyonistlik Bölümü'ne ait koleksiyonları içerir.</subtitle>
<id>http://hdl.handle.net/11513/90</id>
<updated>2026-04-12T02:17:21Z</updated>
<dc:date>2026-04-12T02:17:21Z</dc:date>
<entry>
<title>New prognostic biomarker in cardiovascular field: ST2 (IL1RL1)</title>
<link href="http://hdl.handle.net/11513/133" rel="alternate"/>
<author>
<name>Dikme, Reşat</name>
</author>
<author>
<name>Padak, Mahmut</name>
</author>
<author>
<name>Göz, Mustafa</name>
</author>
<author>
<name>Aydın, Mehmet Salih</name>
</author>
<author>
<name>Göç, Ömer</name>
</author>
<id>http://hdl.handle.net/11513/133</id>
<updated>2019-06-10T11:16:13Z</updated>
<published>2019-01-01T00:00:00Z</published>
<summary type="text">New prognostic biomarker in cardiovascular field: ST2 (IL1RL1)
Dikme, Reşat; Padak, Mahmut; Göz, Mustafa; Aydın, Mehmet Salih; Göç, Ömer
As a result of natural immunity in the heart ST2 (IL1RL1) that protects the heart against excessive pressure load and tension, has two important isoforms&#13;
(ST2L–membranebound, sST2-soluble). As ligand of ST2L and sST2 is interleukin 33 (IL33), the connection of ST2L to IL33 stimulates cardioprotective signal&#13;
cascade whereas connection of sST2 to IL33 causes annihilation of these positive effects. As a high level of sST2 shows that the heart is under dense stress,&#13;
this situation causes cell death, tissue fibrosis, decreased cardiac functions and an increase in progression rate of disease. That is why in cardiovascular disease sST2 is accepted as a biomarker of poor prognosis. It was obtained that the increase of sST2 over normal concentration multiplies negative situations&#13;
related to cardiovascular diseases 3 times more. In 2013 in ACCF/AHA (American College of Cardiology Foundation/American Heart Association) guidelines,&#13;
sST2 that was defined as “novel biomarker” for HF (Heart failure), is an independent biomarker from natriuretic peptides and cardiac troponins and is an&#13;
important sign in cardiovascular diseases. ST2 is not affected by factors such as age, body mass index and kidney function disorder.
</summary>
<dc:date>2019-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Liquid reflecting the heart function: Pericardial fluid</title>
<link href="http://hdl.handle.net/11513/132" rel="alternate"/>
<author>
<name>Dikme, Reşat</name>
</author>
<author>
<name>Padak, Mahmut</name>
</author>
<author>
<name>Göz, Mustafa</name>
</author>
<author>
<name>Aydın, Mehmet Salih</name>
</author>
<author>
<name>Göç, Ömer</name>
</author>
<id>http://hdl.handle.net/11513/132</id>
<updated>2019-06-10T11:12:53Z</updated>
<published>2019-01-01T00:00:00Z</published>
<summary type="text">Liquid reflecting the heart function: Pericardial fluid
Dikme, Reşat; Padak, Mahmut; Göz, Mustafa; Aydın, Mehmet Salih; Göç, Ömer
Pericardium is a sac surrounding the heart and big vessels, protecting them against injury and infection and fixing the heart to the mediastinum. As pericardium&#13;
has an immunologic, paracrine, vasomotor and fibrinolytic activity; it affects myocyte structure, function and gene expression by synthesizing materials such as&#13;
eicosanoids and prostaglandin. Pericardial fluid (PF) in two-walled pericardial sac surrounding the heart completely, has a potential of reflecting heart function&#13;
and shows dynamic changes. Since many biomarkers associated with cardiovascular diseases pass to pericardial sac, PF analysis provides to be understood&#13;
many pathophysiological mechanisms in various pericardial and cardiovascular diseases. The aim of this article is to give actual information about the content&#13;
of PF that is thought to be passive ultrafiltrate of plasma produced with hydrostatic pressure difference and osmotic concentration gradient for years.
</summary>
<dc:date>2019-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>MICRORNAS IN THE PERICARDIAL FLUID OF CORONARY ARTERY PATIENTS</title>
<link href="http://hdl.handle.net/11513/131" rel="alternate"/>
<author>
<name>Dikme, Reşat</name>
</author>
<author>
<name>Gönel, Ataman</name>
</author>
<author>
<name>Koyuncu, İsmail</name>
</author>
<author>
<name>Akkafa, Feridun</name>
</author>
<author>
<name>Göz, Mustafa</name>
</author>
<author>
<name>Aydın, Mehmet Salih</name>
</author>
<author>
<name>Temiz, Ebru</name>
</author>
<id>http://hdl.handle.net/11513/131</id>
<updated>2019-06-10T11:09:09Z</updated>
<published>2018-01-01T00:00:00Z</published>
<summary type="text">MICRORNAS IN THE PERICARDIAL FLUID OF CORONARY ARTERY PATIENTS
Dikme, Reşat; Gönel, Ataman; Koyuncu, İsmail; Akkafa, Feridun; Göz, Mustafa; Aydın, Mehmet Salih; Temiz, Ebru
Background: microRNAs (miRNAs) that play important roles in organisms are associated&#13;
with usual function of cells, development of living, biological processes as well as many&#13;
diseases involving cardiovascular disease. miRNAs are effective in endothelium disfunction,&#13;
atherosclerosis, inflammation, apoptosis and angiogenesis related with coronary artery disease&#13;
(CAD). miRNAs that are explained differently in cells, exist extracellularly, in circulation and&#13;
body fluids. Many biomarkers related with CAD can get through circulation and pericard&#13;
fluid (PF), the closest place to heart. That is why in etiopathogenesis evaluation of CAD&#13;
miRNAs can be used diagnostically in PF and circulation. Since PF has a potential of&#13;
reflecting heart potential, PF concentration of some substances provides to be understood&#13;
many pathophysiological mechanisms.
</summary>
<dc:date>2018-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Oxidative stress and DNA damage during cardiopulmonary bypass</title>
<link href="http://hdl.handle.net/11513/130" rel="alternate"/>
<author>
<name>Dikme, Reşat</name>
</author>
<author>
<name>Göz, Mustafa</name>
</author>
<author>
<name>Aydın, Mehmet Salih</name>
</author>
<author>
<name>Çelik, Hakim</name>
</author>
<author>
<name>Padak, Mahmut</name>
</author>
<author>
<name>Göç, Ömer</name>
</author>
<author>
<name>Taşkın, Abdullah</name>
</author>
<id>http://hdl.handle.net/11513/130</id>
<updated>2019-06-10T11:04:38Z</updated>
<published>2019-01-01T00:00:00Z</published>
<summary type="text">Oxidative stress and DNA damage during cardiopulmonary bypass
Dikme, Reşat; Göz, Mustafa; Aydın, Mehmet Salih; Çelik, Hakim; Padak, Mahmut; Göç, Ömer; Taşkın, Abdullah
Aim: The aim of this study is to measure the oxidative stress index (OSI) and DNA damage in patients undergoing cardiopulmonary bypass (CPB) surgery due&#13;
to coronary artery disease. Material and Method: 25 patients operated for CPB surgery due to coronary artery disease were included in the study. By collecting heparin containing blood from the patients at 5 different times (Before CPB, during pump inlet, during placing of cross clamp, during taking out of cross&#13;
clamp and after CPB) DNA damage was studied by Comet Assay method from mononuclear leucocytes and OSI in plasma was studied. Results: At 5 different&#13;
times plasma OSI value was found respectively as 4.92 ± 1.73, 5.20 ± 2.69, 5.70 ± 2.06, 9.88 ± 4.88, 9.57 ± 4.54 whereas Arbitrary unit (AU), DNA damage&#13;
were determined respectively as 28.48 ± 11.30, 29.04 ± 9.43, 31.44 ± 11.74, 33.92 ± 7.96, 38.56 ± 6.20 AU and p&lt;0.001. Discussion: During CPB, OSI and&#13;
DNA damage gradually increased and a positive meaningful correlation occured between these two parameters (r=0,882 p=0,048). As CPB period extended,&#13;
oxidative stress and DNA damage increased as well as TOS and OSI increased, or vice versa.
</summary>
<dc:date>2019-01-01T00:00:00Z</dc:date>
</entry>
</feed>
